{"version":1,"type":"story","url":"https://digestai.news/story/fda-clears-aletta-the-first-autonomous-blooddraw-robot-for-u-s-clinics","json":"https://digestai.news/story/fda-clears-aletta-the-first-autonomous-blooddraw-robot-for-u-s-clinics.json","markdown":"https://digestai.news/story/fda-clears-aletta-the-first-autonomous-blooddraw-robot-for-u-s-clinics.md","slug":"fda-clears-aletta-the-first-autonomous-blooddraw-robot-for-u-s-clinics","headline":"FDA clears Aletta, the first autonomous blood‑draw robot for U.S. clinics","summary":"Aletta, developed by Dutch robotics firm Vitestro, has received FDA clearance to autonomously draw blood from adults in non‑hospital settings across the United States. The system uses near‑infrared scanning, ultrasound imaging and AI‑driven robotics to locate veins, insert a needle and collect samples without human touch.\n\nIn a Dutch clinical trial of more than 1,600 participants, Aletta succeeded on the first attempt in 94.5% of cases, even with patients who have obesity, elderly age or hard‑to‑find veins. The device can be supervised by a single phlebotomist who may oversee up to three machines, potentially easing the chronic staffing shortages that plague medical labs.\n\nCritics note that the infrared component may struggle with darker skin tones, though Vitestro points to ultrasound as a skin‑tone‑agnostic backup. Ongoing U.S. trials will assess sample quality and broader performance before wider rollout, with plans to expand to Europe next year.","keyPoints":["FDA cleared Aletta, the first autonomous blood‑draw robot, for adult use in U.S. non‑hospital settings.","In a Dutch trial of 1,600+ participants, Aletta succeeded on the first attempt in 94.5% of cases, including hard‑to‑reach veins.","One in twenty draws may fail, with concerns that darker skin tones could reduce infrared imaging accuracy."],"whyItMatters":"Automating phlebotomy could boost lab throughput, lower costs, and mitigate a growing shortage of skilled phlebotomists, while raising equity and safety questions around AI‑driven medical devices.","category":{"slug":"agents","name":"Agents & Tools","url":"https://digestai.news/category/agents"},"entities":{"companies":["Vitestro","Medtronic","Yale University","Mayo Clinic","Rutgers University","MagicNurse"],"models":[],"people":["Max Balter","Joe El-Khoury","Luuk Giesen","Brooke Katzman","Gregory Retzinger","Elie Dolgin"]},"firstPublishedAt":"2026-09-07T13:00:01Z","updatedAt":"2026-09-07T13:00:01Z","sourceCount":1,"hasPrimarySource":false,"sources":[{"outlet":"IEEE Spectrum Robotics","title":"This Robot Will Draw Your Blood Now","url":"https://spectrum.ieee.org/blood-draw-robot-vitestro-aletta","publishedAt":"2026-09-07T13:00:01Z","type":"press","primary":false,"lead":true}],"sourceNotes":null,"discussions":[],"thread":null,"cite":{"text":"Digest AI, \"FDA clears Aletta, the first autonomous blood‑draw robot for U.S. clinics\", 7 September 2026, https://digestai.news/story/fda-clears-aletta-the-first-autonomous-blooddraw-robot-for-u-s-clinics","publisher":"Digest AI","title":"FDA clears Aletta, the first autonomous blood‑draw robot for U.S. clinics","datePublished":"2026-09-07T13:00:01Z","url":"https://digestai.news/story/fda-clears-aletta-the-first-autonomous-blooddraw-robot-for-u-s-clinics"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}